SCHEMBL13298463

SCHEMBL13298463

c1ccc([SiH2]c2ccc3c(-c4ccc5ccccc5c4)c4ccccc4c(-c4ccccc4)c3c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 6/20 0.40
▸ ESR2 Q92731 6/20 0.40
▸ HSD17B1 P14061 2/20 0.36
▸ HSD17B2 P37059 2/20 0.36
▸ CYP1A1 P04798 2/20 0.36
▸ CYP1B1 Q16678 2/20 0.36
▸ CYP1A2 P05177 2/20 0.35
▸ IKBKB O14920 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2B6 P20813 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ GPR84 Q9NQS5 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13298459 1.00 ESR1 (0.40) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL13298490 0.99 ESR1 (0.39) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL13298515 0.96 ESR1 (0.40) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL13298507 0.96 ESR1 (0.40) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL13298552 0.94 HSD17B1 (0.41) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL13298550 0.94 HSD17B1 (0.41) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL13298576 0.93 ESR1 (0.35) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL13298534 0.93 HSD17B1 (0.40) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL13298572 0.93 ESR1 (0.35) ESR1ESR2HSD17B1HSD17B2CYP1A1
SCHEMBL13298537 0.93 HSD17B1 (0.40) ESR1ESR2HSD17B1HSD17B2CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same DONGJIN SEMICHEM CO., LTD (KR) 2010-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same TRPA1, TRPM2, TRPM4 ESR1 226/4885ESR2 1338/4885HSD17B1 2150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback